Med spa patient retention is the share of treated patients who return within the interval their treatment actually runs on, which makes it a scheduling measurement before it is a loyalty one. The rate moves on two things most practices never set deliberately: when the next visit is booked, and what window the rate is counted over.
Why retention is the margin
Retention is where med spa margin lives because a returning patient costs nothing like a new one. Growth99's 2026 report, published by AmSpa in January 2026, puts average new-patient acquisition at $132 against an average visit value of $527, and says 73% of revenue comes from repeat patients. Those are cross-channel averages with no stated survey size or method.
Read in that direction, the arithmetic is uncomfortable for a practice buying leads. The second visit from a patient already in the record carries no acquisition cost at all, only the cost of asking. A practice that lifts the share of patients returning on interval is buying revenue at a price no ad account can match, and it is doing it with information it already owns.
That is also why retention is the first thing to measure and the last thing to outsource to a channel. Email and texting are how a recall gets delivered. They are not what decides whether the patient was ever going to come back, which is settled earlier, in the room.
The interval belongs to the treatment, not to the calendar
A recall interval is a clinical fact, not a marketing choice. The FDA-approved prescribing information for BOTOX Cosmetic states that injection intervals should be no more frequent than every three months, performed at the lowest effective dose, and puts the duration of effect for glabellar lines at roughly three to four months. The protocol belongs to the medical director.
This is the detail that breaks most retention programs before they start. A monthly newsletter cannot recall a patient whose treatment runs on a quarterly cycle, because eleven of its twelve sends arrive at a patient with no reason to book. The interval has to be stored against the treatment on the record, and the recall has to read it.
| Treatment | What sets the return interval | What the recall fires from |
|---|---|---|
| Neurotoxin | Product labeling and the injector's protocol; FDA labeling for BOTOX Cosmetic sets a floor of no more frequent than every three months | That patient's own treatment date |
| Dermal filler | Product longevity and the medical director's review schedule | The review appointment booked at checkout |
| Laser or energy-based series | The session count and spacing fixed before the series starts | The next session in the series, booked at checkout |
| Medical weight management | The prescriber's follow-up schedule | The follow-up or prescription date |
| Facials and skin maintenance | The practice's own written protocol | The date of the last visit |
The rebook happens at checkout or it happens by accident
The highest-yield retention move in a med spa costs nothing and takes fifteen seconds: the next appointment is booked before the patient leaves, at the interval the treatment runs on. Every recall sequence that fires weeks later is a backstop for the practices that skipped it, and a backstop converts worse than the original ask.
It works because the conditions are never again this good. The patient is present, the result is fresh, the injector has just said when they want to see them, and the calendar is open on the screen. Four weeks later the same request arrives as a notification competing with everything else in a phone.
Making it a rule rather than a habit is the whole job. Who asks, at what point in checkout, in what words, and what happens when the patient will not commit to a date: that last one is where most practices quietly stop, and the answer is a provisional slot they can move, not a note to call them later.
What a retention rate is measured against
A retention rate is meaningless until the window is named, and the window has to be at least as long as the interval of the treatment being measured. Counted over a calendar month, a neurotoxin patient doing everything right looks lapsed in eleven months out of twelve. Change the denominator and the same practice reads as healthy or failing.
| Measured over | What it counts | What it gets wrong |
|---|---|---|
| A calendar month | Patients who returned inside the month | Counts a patient on a compliant three-month interval as lapsed almost every month |
| The treatment's own interval | Patients who returned before their interval expired | Needs the interval recorded per treatment, which most platform reports do not carry |
| A rolling twelve months | Patients still active across every interval on the menu | Hides a recent collapse behind a year of older history |
The usable version is the middle row, reported per treatment and rolled up afterwards. It answers the question an owner actually has, which is whether people are coming back when they are supposed to, and it localises a problem to a treatment or an injector instead of smearing it across the practice.
What the recall sequence can and cannot do
A recall sequence recovers the patients who left without rebooking and reaches the ones who have drifted past their interval. It cannot create an interval that was never recorded, and it cannot rescue a practice that books nothing at checkout. Treat it as the second line, sized to the gap the first line leaves.
The delivery rules differ by channel and are covered in full elsewhere in this cluster: email runs on an opt-out default, texting on an opt-in one. On privacy, note that under 45 CFR 164.508 a covered entity must obtain an authorization before protected health information is used for marketing, with narrow exceptions for a face-to-face communication and a promotional gift of nominal value. Whether a practice is a covered entity turns on the electronic transactions it runs, and that is a question for the practice's healthcare attorney.
What this looks like when it runs
Automated booking systems are the buyer criterion this sits under, and the working version books the next visit before the patient leaves: the interval stored on the treatment record, the next slot offered at checkout, and a recall that fires from that date rather than from a monthly send.
Mirastart builds that layer. Booking systems that calculate genuine availability and send confirmations automatically, follow-up automation that chases what people forget, loyalty and membership software, and reporting that counts outcomes rather than sends all run in production for Charlotte businesses today. They sit on whichever platform already holds the calendar wherever an API exists, and beside it where one does not.
Reporting is the part worth insisting on. A retention report that leads with messages delivered is measuring the agency; one that leads with patients returned on interval, by treatment, is measuring the practice. The second is the only one that tells an owner whether to change anything.
On privacy the controls are worth checking on any agency, ours included: patient information stays out of ad platforms and pixels, form submissions land in a system the practice owns, and we sign a business associate agreement where an engagement touches protected health information. The practice stays the covered entity.
Sources
- The Marketing Investment Gap (American Med Spa Association, byline Growth99) - Growth99's 2026 State of Aesthetic & Elective Wellness Marketing Report, published on AmSpa's site January 9, 2026: average cost per lead $39, new patient acquisition $132, average visit value $527, and 73% of revenue from repeat patients. Growth99 is a marketing vendor reporting its own survey; survey size and method are not stated.
- BOTOX Cosmetic (onabotulinumtoxinA) prescribing information (U.S. Food and Drug Administration) - FDA-approved labeling: injection intervals of BOTOX Cosmetic should be no more frequent than every three months and should be performed using the lowest effective dose; duration of effect for glabellar lines is approximately three to four months. Treatment protocol is the medical director's, not a marketing decision.
- 45 CFR § 164.508 - Uses and disclosures for which an authorization is required (HIPAA Privacy Rule) - A covered entity must obtain an authorization for any use or disclosure of protected health information for marketing, except a face-to-face communication or a promotional gift of nominal value. Cornell LII mirror of the eCFR; official text at ecfr.gov. Whether a practice is a covered entity turns on 45 CFR 160.103, not this section.